Mario Gualano

BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

BBI Group Ltd. operates as a resource and energy exploration company. Its projects include include Balla Balla and Eucla West Mineral Sands. The company was founded on October 8, 2009 and is headquartered in Sydney, Australia.

Part of Venture Life Group Plc, BBI Healthcare Ltd. distributes drugs and health supplements. The private company is based in Pencoed, UK. The British company was founded in 2005. BBI Healthcare was acquired by Venture Life Group Plc from BBI Diagnostics Group Ltd. on June 07, 2021 for $37.41 million.

BBI Solutions OEM Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. It offers gold reagents, antibodies, antigens, biobank, cell culture, reagents, and enzymes. The firm services include lateral flow assay development, lateral flow test manufacture, and case studies. The company was founded in John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Part of Novo Nordisk Fonden, Eagle SPV 2 Ltd. is an investment holding British company. The private company is based in Cardiff, UK. Eagle SPV 2 was founded in 2015.

Part of Novo Nordisk Fonden, Eagle SPV 3 Ltd. is a British company that provides professional, scientific and technical services. The private company is based in Cardiff, UK. Eagle SPV 3 was founded in 2015.

BBI Group Holding Ltd. develops and distributes diagnostic equipment. The firm offers gold nanoparticles, assay reagents, contract lateral flow test development, human proteins, enzymes, antibodies, gold conjugates, lateral flow assay development, patient samples, disease state plasma, and biobank. The company was founded by John Chandler in 1986 and is headquartered in Crumlin, the United Kingdom.